Stock events for Teladoc Health, Inc. (TDOC)
In April 2025, Teladoc Health reported its Q1 earnings, announced the acquisition of UpLift Health Technologies, and launched its next-generation Cardiometabolic Health Program; Q1 revenue increased, but total visits decreased. In July 2025, the company released its Q2 earnings, reporting an EPS that topped estimates and revenue exceeding expectations, while reaffirming its full-year outlook; Mizuho initiated coverage with a "neutral" rating, and the company launched the "Wellbound" employee assistance program. In October 2025, the CFO announced her departure, the company reaffirmed its full-year outlook, and preliminary Q3 results showed revenue slightly surpassing estimates and adjusted EBITDA exceeding expectations, despite a net loss; the stock saw an increase following these announcements, with analyst upgrades and increased price targets, though Weiss Ratings reiterated a "sell" rating; the company also launched a new AI-enabled workplace violence prevention capability.
Demand Seasonality affecting Teladoc Health, Inc.’s stock price
While there aren't explicit details of strong seasonal demand patterns, Teladoc Health's virtual visits have shown some fluctuations, remaining relatively stable above 4.5 million for six consecutive quarters as of August 2023. However, total visits slipped in Q1 2024, and the BetterHelp segment experienced a revenue drop in Q3 2024 due to lower user additions and a decline in average paying users, reflecting headwinds in the U.S. cash pay business and softening consumer sentiment. This indicates that specific segments can be influenced by market conditions and broader consumer behavior rather than distinct seasonal cycles.
Overview of Teladoc Health, Inc.’s business
Teladoc Health, Inc. is a multinational telemedicine and virtual healthcare company operating in the Health Care sector, specifically in Health Care Technology and Medical/Nursing Services. It connects patients with doctors and specialists through online platforms, using telephone, videoconferencing, and mobile apps for remote medical care. The company's major products and services are categorized into Teladoc Health Integrated Care and BetterHelp. The Integrated Care segment offers virtual medical services, including consultations, expert opinions, specialty care, chronic condition management, and mental health support, along with enabling technologies. The BetterHelp segment is a direct-to-consumer mental health platform offering online counseling and therapy. Teladoc Health generates revenue through subscription access fees and visit fees.
TDOC’s Geographic footprint
Teladoc Health, Inc. has a significant global presence, operating in over 130 countries across the Americas, Europe, and Asia-Pacific.
TDOC Corporate Image Assessment
Teladoc Health has been recognized on several Forbes lists, including "America's Best Employers For Company Culture (2025)", "America's Best Employers for Women (2025)", "America's Best Large Employers (2025)", and "America's Dream Employers (2025)". The company was also listed in "America's Best Employers for Diversity (2024)" and "Most Cybersecure Companies (2023)". However, the company's stock performance has led to some negative sentiment regarding its investment outlook, with concerns about whether Teladoc is a "Hidden Bargain or a Value Trap" and if its stock is "worth the hype". Renewed investor caution arose due to slow revenue growth, declining average revenue per user, and flat sales forecasts.
Ownership
Teladoc Health, Inc. is predominantly owned by institutional investors, who hold approximately 72.60% to 76.82% of the company's stock. Major institutional owners include Vanguard Group Inc, BlackRock, Inc., Point72 Asset Management, L.P., Renaissance Technologies Llc, Dimensional Fund Advisors Lp, State Street Corp, and Geode Capital Management, Llc. HLM Venture Partners II LP is noted as the largest individual shareholder.
Ask Our Expert AI Analyst
Price Chart
$8.14